Nutech Global (531304)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Shares trade at a P/B of 0.98, slightly below book value of ₹18.09, offering a modest asset-based floor.
• Sales growth of 58.87% and profit growth of 209.09% indicate recent positive momentum from a small base.
• Piotroski F-Score of 7/9 suggests decent recent financial health across profitability, leverage, and efficiency.
• PEG ratio of 0.14 appears low, though it is unreliable given the latest quarter's zero net profit.

Concerns

• Latest quarter net profit is ₹0 Cr despite ₹11 Cr sales, making earnings power inconsistent.
• ROE of 4.49% and ROCE of 5.17% show weak returns on capital and a poor compounding profile.
• P/E of 30.31 is expensive for near-zero quarterly earnings, and there is no dividend yield.
• Promoter holding and debt/equity are not available, limiting assessment of governance and leverage.

AI Analysis

I begin with a simple test: do I understand the business and does it earn attractive returns on capital? Nutech Global is a microcap—market cap ₹6 Cr—in 'Other Textile Products', a commodity and highly competitive segment. The figures do not pass my quality test. Book value stands at ₹18.09 per share while the share trades at ₹17.68, so on the surface I am buying at roughly a 2% discount to book. But that book earns only a 4.49% return on equity; ROCE is 5.17%. A business that cannot generate returns meaningfully above its cost of capital is not a wealth compounder. The latest quarter had sales of ₹11 Cr and net profit of ₹0 Cr. That is a red flag: annual profit growth of 209.09% and sales growth of 58.87% look wonderful, but they start from a tiny, volatile base. Paying a P/E of 30.31 for this inconsistent earning power is not something I would do. The Piotroski F-score of 7/9 tells me recent financial health is okay, but F-scores can improve while the business remains mediocre. There is no dividend, so my return depends entirely on asset values and future earnings. The stock is already below the stated 52-week low, which tells me Mr. Market is not bidding for this name. In the Graham tradition, I look for margin of safety. A P/B of 0.98 is a small cushion, but with low ROE, zero quarterly profit, and no promoter holding information, I cannot trust that the assets are deployed for shareholders. This looks closer to a possible asset play than a wonderful business. I will wait until earnings are consistent, returns on capital improve, and management's actions become visible before investing.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer